Oak Ridge Investments’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Oak Ridge Investments’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-17,632	Closed	-$163K	–	160
2014 Q4	$163K	Sell	17,632 -1,736	-9%	-$14.6K	﹤0.01%	144
2014 Q3	$173K	Hold	19,368	–	–	﹤0.01%	144
2014 Q2	$152K	Buy	19,368 +962	+5%	+$7.27K	﹤0.01%	143
2014 Q1	$146K	Buy	18,406 +7,351	+66%	+$59.1K	﹤0.01%	140
2013 Q4	$69K	Buy	+11,055	New	+$58K	﹤0.01%	134

Other funds holding CORV

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Oak Ridge Investments's CORV Position: Q1 2015 in Review

Oak Ridge Investments sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q1 2015, closing a stake of 17,632 shares — an estimated $163K sold.

Oak Ridge Investments first reported a position in CORV in Q4 2013 and held it in 5 quarters. The position peaked at $173K in Q3 2014. 32 funds tracked by Wall St. Rank hold CORV as of Q1 2015.

Oak Ridge Investments reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q1 2015 after selling out during the quarter.
Oak Ridge Investments sold 17,632 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q1 2015, an estimated $163K.
Oak Ridge Investments first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2013 and held it in 5 quarters.
Oak Ridge Investments's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $173K in Q3 2014.
32 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q1 2015.

Based on Oak Ridge Investments's 13F filing for Q1 2015, filed 12 May 2015.